JD Supra20m
FDA Finalizes Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products
On January 6, 2025, the FDA released final guidance for industry entitled “Communications From Firms to Health Care Providers Regarding ...
ConsumerAffairs3d
FDA approves 20 ZYN nicotine pouches after thorough' safety review
The U.S. Food and Drug Administration (FDA) has approved 20 ZYN nicotine "pouch" products for sale after what it called "a ...
Food Republic on MSN5d
The FDA Could Be Making Major Changes To Nutrition Labels. Here's What To Know
The FDA might soon change the appearance of food labels to more clearly inform consumers about the nutrition information in ...
infectiousdiseaseadvisor.com11d
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
To combat chronic diseases, FDA proposes putting nutrition labels on front of packages
The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, ...
Cancer risk prompts FDA ban on red food dye
On Wednesday, the Food and Drug Administration (FDA) issued an order that will ban Red No. 3, a synthetic dye, from food, ...
New FDA proposal would put 'front-of-package' nutrition labels on food products
The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...
Marijuana Moment4d
FDA Seeks Veterinarians’ Input On Use Of CBD And Other Cannabis Products In Animals
The Food and Drug Administration is asking for comments from veterinarians and the broader public about the use of ...
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets
TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceuticals, Inc. ("Handa") (6620.TWO) announced that its U.S.